Phase II trial of pegylated-liposomal doxorubicin in the treatment of locally advanced unresectable or metastatic transitional cell carcinoma of the urothelial tract
To access this article, please choose from the options below
PII: S0959-8049(03)00358-7
doi:10.1016/S0959-8049(03)00358-7
© 2003 Elsevier Science Ltd. All rights reserved.
